SCHEMBL9722748

SCHEMBL9722748

Nc1nc2ccc(-c3ccc(Cl)cc3)cc2s1

nearest known ligand 0.74

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 12/20 0.73
PI4KA P42356 12/20 0.73
PI4KB Q9UBF8 12/20 0.73
PIK3CD O00329 11/20 0.71
PIK3CG P48736 9/20 0.71
PIK3CB P42338 8/20 0.71
PIP5K1C O60331 4/20 0.71
EPHX2 P34913 1/20 0.57
ALKBH5 Q6P6C2 1/20 0.56
FTO Q9C0B1 1/20 0.56
APP P05067 1/20 0.55
MAPT P10636 1/20 0.54
RAB9A P51151 1/20 0.54
AXL P30530 1/20 0.54
GFER P55789 1/20 0.54
GAA P10253 1/20 0.54
HTT P42858 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31114470 1.00 PIK3CA (0.73) PIK3CAPI4KAPI4KBPIK3CDPIK3CG
SCHEMBL5532470 0.89 PIK3CA (0.82) PIK3CAPI4KAPI4KBPIK3CDPIK3CG
SCHEMBL29646253 0.89 PIK3CA (0.82) PIK3CAPI4KAPI4KBPIK3CDPIK3CG
SCHEMBL16296381 0.86 PIK3CA (0.77) PIK3CAPI4KAPI4KBPIK3CDPIK3CG
SCHEMBL77839 0.85 RAB9A (0.61) PIK3CAPI4KAPI4KBPIK3CDPIK3CG
SCHEMBL25304004 0.85 PIK3CA (0.66) PIK3CAPI4KAPI4KBPIK3CDPIK3CG
SCHEMBL31114629 0.85 PIK3CA (0.66) PIK3CAPI4KAPI4KBPIK3CDPIK3CG
SCHEMBL8773471 0.84 PIK3CA (1.00) PIK3CAPI4KAPI4KBPIK3CDPIK3CG
Hydrochloric Acid SCHEMBL10831817 0.84 RAB9A (0.59) PIK3CAPI4KAPI4KBPIK3CDPIK3CG
Hydrochloric Acid SCHEMBL27769376 0.84 RAB9A (0.59) PIK3CAPI4KAPI4KBPIK3CDPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250382273-A1 BENZOTHIAZOLE ANAOLOGUES AND USE THEREOF AS BOOSTERS OF ANTI TUBERCULOSIS DRUGS INST NAT SANTE RECH MED (FR) 2025-12-18 US disclosed
EP-4460500-A1 BENZOTHIAZOLE ANAOLOGUES AND USE THEREOF AS BOOSTERS OF ANTI TUBERCULOSIS DRUGS INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE - INSERM (FR) 2024-11-13 EP disclosed
WO-2023131649-A1 BENZOTHIAZOLE ANAOLOGUES AND USE THEREOF AS BOOSTERS OF ANTI TUBERCULOSIS DRUGS INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2023-07-13 WO disclosed
WO-2023131649-A1 BENZOTHIAZOLE ANAOLOGUES AND USE THEREOF AS BOOSTERS OF ANTI TUBERCULOSIS DRUGS INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2023-07-13 WO disclosed
US-5120872-A Textile dyeing CIBA-GEIGY CORPORATION (US) 1992-06-09 US disclosed
US-4994563-A Dyeing, printing cellulose, silk, wool, synthetic polyamides; colorfastness CIBA-GEIGY CORPORATION (US) 1991-02-19 US disclosed
EP-0349486-A2 Azo dyes, their preparation and their use CIBA-GEIGY AG (CH) 1990-01-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250382273-A1 BENZOTHIAZOLE ANAOLOGUES AND USE THEREOF AS BOOSTERS OF ANTI TUBERCULOSIS DRUGS BBOX1, NDUFB6, NDUFB5 PIK3CA 3378/4885PI4KA 4333/4885PI4KB 3022/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.